Hester Biosciences Limited

NSE HESTERBIO.NS

Hester Biosciences Limited Free Cash Flow Yield on February 06, 2025: 1.53%

Hester Biosciences Limited Free Cash Flow Yield is 1.53% on February 06, 2025, a 134.09% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Hester Biosciences Limited 52-week high Free Cash Flow Yield is 2.18% on June 04, 2024, which is 42.10% above the current Free Cash Flow Yield.
  • Hester Biosciences Limited 52-week low Free Cash Flow Yield is -4.92% on March 13, 2024, which is -421.02% below the current Free Cash Flow Yield.
  • Hester Biosciences Limited average Free Cash Flow Yield for the last 52 weeks is 0.53%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
NSE: HESTERBIO.NS

Hester Biosciences Limited

CEO Mr. Rajiv Dinesh Gandhi B.Com
IPO Date March 13, 2015
Location India
Headquarters Pushpak
Employees 642
Sector Consumers Staples
Industries
Description

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Similar companies

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 19.59

-0.12%

SHILPAMED.NS

Shilpa Medicare Limited

USD 8.59

1.52%

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 24.85

-1.27%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 165.33

-2.52%

ERIS.NS

Eris Lifesciences Limited

USD 16.59

4.28%

StockViz Staff

February 8, 2025

Any question? Send us an email